Appendix A
Schedule of Data-Gathering
Data Gathering Meeting 1: February 29-March 1, 2012 in Washington, DC
The committee received overview presentations of the CBDP from the following people:
Dr. Gerald Parker, Deputy Assistant Secretary of Defense for Chemical and Biological Defense
Dr. Robert Cohn, Chief Scientist, Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs/Chemical and Biological Defense
BG Lucas Polakowski, Deputy Director for Force Protection and Counter Weapons of Mass Destruction, J8
BG Jess Scarborough, Joint Program Executive Officer for Chemical and Biological Defense
Mr. James Cooke, Deputy Under Secretary of the Army for Test and Evaluation
Mr. Lenny Izzo, Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense
Dr. Alan Rudolph, Director, Chemical and Biological Technologies Directorate, Defense Threat Reduction Agency (DTRA)
In addition to these individuals, the committee heard panel presentations focused on specific capability focus areas. Participants in these panels came from multiple offices from throughout the CBDP enterprise. The
focus areas were Surveillance, Medical Countermeasures, Enabling Technologies, and Hazard Mitigation. The committee also received a threat assessment briefing.
Data Gathering Meeting 2: March 15, 2012 in Dugway, UT
A subgroup of the committee visited Dugway Proving Ground in Dugway, UT. The group met with representatives of the facility and heard overview presentations about the site’s capabilities and activities. The group also held roundtable discussions with local project managers, senior scientists, and management personnel. The committee toured the Materiel Test Facility, the Combined Chemical Test Facility, the Life Sciences Test Facility, and the Joint Ambient Breeze Tunnel.
The committee met with the following individuals:
COL A. Scott Estes, Commander, DPG
SGM Stanley Morton, Jr., Command Sergeant Major, DPG
Dr. Kenneth Gritton, Technical Director, WDTC
Mr. Ryan Harris, Acting Director, WDTC
Mr. Chris Johnson, Chief, WDTC Operations Division
Dr. Chris Olson, Chief, WDTC Chemical Test Division
Mr. Jeff Garcia, Acting Chief, WDTC Dissemination & Explosives Division
Dr. Doug Andersen, Chief, WDTC Life Sciences Division
Mr. Ross Rosengren, Chief, Resource Management
Mr. Bill Brown, Test Engineering & Integration Division
Data Gathering Meeting 3: March 16, 2012 in Natick, MA
A subgroup of the committee visited the US Army Natick Soldier Research, Development, and Engineering Center in Natick, MA. The group met with representatives of the facility and heard overview presentations about the site’s capabilities and activities. The group also participated in a roundtable discussion with principle investigators and senior scientists. The committee toured and met with personnel from the following programs: Human Factors Lab and Assessment, the Molecular Science & Engineering Team, ARIEM and the Doriot Chambers, and Collective Protection and Shelters. The committee met with individuals, including: Dr. Heidi Gibson, Natick Soldier Research, Development and Engineering Center, Polymer Research Chemist.
Data Gathering Meeting 4: March 19-20, 2012 at Various Locations
March 19, Washington, DC
The committee heard a number of briefings from representatives from agencies and individuals that have programs relevant to the CBDP initiatives or capability focus areas.
Robert Kadlec, RPK Consulting LLC
Randall Long, Director, Chemical and Biological Division, Science and Technology Directorate, Department of Homeland Security
Susan Coller-Monarez, Threat Characterization and Attribution Branch Chief, Chemical and Biological Defense Division Science and Technology Directorate, Department of Homeland Security
Elizabeth George, Director of the Cooperative Threat Reduction Directorate, Defense Threat Reduction Agency, Department of Defense
Carol Linden, Principal Deputy Director, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services
Mike Kurilla, Director, Office of BioDefense Research Affairs, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Rick Jaffe, Director, Medical Countermeasures, Strategy, and Requirements, Office of Policy and Planning, Health and Human Services
Luciana Borio, Assistant Commissioner for Counterterrorism Policy and Director, Office of Counterterrorism and Emerging Threats, Food and Drug Administration
March 20, Frederick, MD
A subgroup of the committee visited US Army Medical Research Institute for Infectious Diseases (USAMRIID) at Ft. Detrick in Frederick, MD. The group met with representatives of the facility and heard overview presentations about the site’s capabilities and activities. The committee also toured BSL-2, BSL-4, and ECO facilities and toured the aerobiology laboratory. During the meeting, the group also participated in roundtable discussions with the senior scientists, program managers, and management personnel.
The committee met with the following individuals:
COL Bernard DeKoning, Commander
COL Andrea Stahl, Deputy Commander
COL Brian Gentile, Director for Administration
SGM Thomas Tuttle, Sergeant Major
Dr. Leonard Smith, Acting Science Director
Dr. Connie Schmaljohn, Senior Research Scientist
Dr. Arthur Friedlander, Supervisory Research Medical Officer
Dr. Mark Dertzbaugh, Chief, Business Plans and Programs
COL Fernando Guerena, Chief, Division of Medicine
LTC Neal Woollen, Director of Safety, Security, and Biosurety
Dr. David Norwood, Chief, Diagnostic Systems Division
Dr. Jeffrey Teska, NICBR Partnership Office
Dr. Aysegul Nalca, Chief, Center for Aerobiological Sciences
Dr. Patricia Worsham, Chief, Bacteriology Division
Dr. Louise Pitt, Chief, Virology Division
Dr. Sina Bavari, Chief, Integrated Toxicology Division
Mr. James Coffman, Chief, Office of Research and Technology Applications
Ms. Caree Vander Linden, Public Affairs Office
COL Randall Rietcheck, Director, Veterinary Medicine Division
LTC Pedro Rico, Chief, Pathology Division
March 20, Aberdeen, MD
A subgroup of the committee visited US Army Medical Research Institute for Chemical Defense (USAMRICD) and Edgewood Chemical Biological Center (ECBC) at Aberdeen Proving Ground in Aberdeen, MD. The group met with representatives, took tours of the facilities, and heard overview presentations about the site’s capabilities and activities.
At USAMRICD, the committee toured the laboratories and facilities for molecular modeling, chemical surety, behavioral studies, mass spectrometry and analytical chemistry, and the vivarium. The presentations and tours were led by the following people:
COL Peter Schultheiss, Commander
COL Deborah Whitmer, Deputy Commander
Dr. John Graham, Deputy to the Commander for Research
Dr. James Dillman, Chief, Research Program Office
Dr. Doug Cerasoli, Program Advisor, Molecular and Cellular Therapeutics
Dr. Lucille Lange, Program Advisor, Toxicologic Modeling
LTC Rick Probst, Deputy Chief, Research Support Division
Dr. Ben Capacio, Program Advisor, Medical Diagnostics and Forensics
Mr. Jonathon Oyler, Chemist, Team Leader for BB Area
The committee also met with program advisors and deputy program advisors, division chiefs and deputy division chiefs, and management personnel for a roundtable discussion.
At ECBC the committee toured the McNamara Life Science Building, which houses the inhalation chamber, the standoff detection team, the genomics laboratory, and BSL-3 laboratories; the Mobile Laboratory Systems; the Advanced Chemistry Laboratory, which houses Decontamination Science, the Filter Testing Laboratory, and the Synthesis Laboratory; and the Sample Receipt Facility. Following the facility tours, committee members met with the principle investigators for wrap-up discussions then returned to the original meeting room for a roundtable discussion with facility management personnel.
The presentations and tours were led by the following people:
Dr. Joseph Corriveau, Director, Research and Technology
COL Ray Compton, Military Deputy
Dr. John Carpin, Biomedical Engineer
Dr. Christopher Whalley, (Acting) Division Chief, Toxicology and Obscurants
Dr. Mary Wade, (Acting) Branch Chief, BioDefense
Mr. Richard Vanderbeek, Branch Chief, Laser Standoff Detection
Dr. Sandy Gibbons, Research Microbiologist
Dr. Carrie Poore, Team Leader, Advanced CBRNE Training Team
Mr. George Noya, Team Leader, Mobile Labs and Kits Team
Dr. Teri Lalain, Branch Chief, Decontamination Sciences
Dr. Brent Mantooth, Principle Investigator, Modeling Simulation and Analysis
Mr. Matt Shue, (Acting) Branch Chief, Decontamination Sciences
Dr. Frederick Cox, (Acting) Division Chief, CB Protection and Decontamination
Dr. Fred Berg, Division Chief, Chemical Sciences
Mr. Chris Druyor, Chemical Engineering Technician
Mr. Jerry Pfarr, Microbiologist, Chemical Operations Branch
Data Gathering Meeting 5: April 3, 2012 in Washington, DC
The committee invited representatives from all of the DOD Combatant Commands and the Services to brief the group on their perspectives on the CBD Program and its objectives and capabilities. At its fifth meeting, the committee held discussions with representatives from US European Command and US Northern Command. The committee also spoke with US DOD Service representatives to the Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense from the US Army and US Marines. Due to unforeseen circumstances, US Strategic Command and the Service representative from the US Air Force were unable to participate.
At this meeting, the committee also held roundtable discussions with program managers from the Joint Science Technology Office and the Joint Program Executive Office for Chemical and Biological Defense.
The committee was also briefed by Dr. Julie Pavlin, Deputy Director, Armed Forces Health Surveillance Center (AFHSC) and Acting Chief, Global Emerging Infections Surveillance & Response System (GEIS), on GEIS and its activities.
Data Gathering Meeting 6: April 18, 2012 in Washington, DC
The committee held discussions with representatives from US Special Operations Command on the CBD Program and its objectives and capabilities.